Implications for Photocarcinogenesis Presentation by Langerhans Cells :-Urocanic Acid on Tumor Antigen cis IL-12 Prevents the Inhibitory Effects of

[1]  M. Norval,et al.  cis-Urocanic Acid does not Induce the Expression of Immunosuppressive Cytokines in Murine Keratinocytes¶,† , 2001, Photochemistry and photobiology.

[2]  T. Mohammad,et al.  A CONVENIENT SYNTHESIS OF cis-UROCANIC ACID, AN ENDOGENOUS IMMUNOSUPPRESSANT , 2000 .

[3]  J. Bluestone,et al.  Reduced ultraviolet-induced carcinogenesis in mice with a functional disruption in B7-mediated costimulation. , 1999, Journal of immunology.

[4]  S. Beissert,et al.  Mechanisms involved in ultraviolet light-induced immunosuppression. , 1999, The journal of investigative dermatology. Symposium proceedings.

[5]  L. Austin,et al.  312-nanometer Ultraviolet B Light (Narrow-Band UVB) Induces Apoptosis of  T Cells within Psoriatic Lesions , 1999, The Journal of experimental medicine.

[6]  H. HogenEsch,et al.  Urocanic Acid Photochemistry and Photobiology , 1999, Photochemistry and photobiology.

[7]  T. Luger,et al.  Impaired cutaneous immune responses in Thy-1-deficient mice. , 1998, Journal of immunology.

[8]  J. Simon,et al.  Physiologic doses of urocanic acid do not alter the allostimulatory function or the development of murine dendritic cells in vitro , 1997, Photodermatology, photoimmunology & photomedicine.

[9]  F. Urbach,et al.  Ultraviolet radiation and skin cancer of humans. , 1997, Journal of photochemistry and photobiology. B, Biology.

[10]  S. Beissert,et al.  Regulation of tumor antigen presentation by urocanic acid. , 1997, Journal of immunology.

[11]  J. Streilein,et al.  Ultraviolet B-exposed and soluble factor-pre-incubated epidermal Langerhans cells fail to induce contact hypersensitivity and promote DNP-specific tolerance. , 1997, The Journal of investigative dermatology.

[12]  F. Claas,et al.  Differential Suppression of the Human Mixed Epidermal Cell Lymphocyte Reaction (MECLR) and Mixed Lymphocyte Reaction (MLR) by Cis‐Urocanic Acid , 1997, Photochemistry and photobiology.

[13]  S. Beissert,et al.  UV-induced cutaneous photobiology. , 1996, Critical reviews in biochemistry and molecular biology.

[14]  J. Streilein,et al.  Failed antigen presentation after UVB radiation correlates with modifications of Langerhans cell cytoskeleton. , 1996, The Journal of investigative dermatology.

[15]  C. Bucana,et al.  Evidence that DNA damage triggers interleukin 10 cytokine production in UV-irradiated murine keratinocytes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[16]  G. Trinchieri,et al.  Interleukin-12 prevents ultraviolet B-induced local immunosuppression and overcomes UVB-induced tolerance. , 1996, The Journal of investigative dermatology.

[17]  C. Bucana,et al.  Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice , 1996, The Journal of experimental medicine.

[18]  G. Trinchieri,et al.  Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and induces hapten-specific tolerance. , 1996, Journal of immunology.

[19]  A. Enk,et al.  IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. , 1995, Journal of immunology.

[20]  M. Norval,et al.  Urocanic acid isomers in human skin: analysis of site variation , 1995, The British journal of dermatology.

[21]  M. Norval,et al.  A monoclonal antibody to cis-urocanic acid prevents the ultraviolet-induced changes in Langerhans cells and delayed hypersensitivity responses in mice, although not preventing dendritic cell accumulation in lymph nodes draining the site of irradiation and contact hypersensitivity responses. , 1995, The Journal of investigative dermatology.

[22]  L. Owen-Schaub,et al.  Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation. , 1995, Journal of immunology.

[23]  S. Beissert,et al.  IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. , 1995, Journal of immunology.

[24]  G. Trinchieri,et al.  IL-12 is expressed and released by human keratinocytes and epidermoid carcinoma cell lines. , 1994, Journal of immunology.

[25]  A. Enk,et al.  Identification and induction of human keratinocyte-derived IL-12. , 1994, The Journal of clinical investigation.

[26]  R. Gieseler,et al.  Prolongation of survival of small bowel transplant recipients after treatment with cis-urocanic acid. , 1994, Transplantation proceedings.

[27]  M. Norval,et al.  Characterization of a monoclonal antibody to cis-urocanic acid: detection of cis-urocanic acid in the serum of irradiated mice by immunoassay. , 1993, Immunology.

[28]  S. Ullrich,et al.  Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. , 1992, Journal of immunology.

[29]  J. Streilein,et al.  Deleterious effects of cis-urocanic acid and UVB radiation on Langerhans cells and on induction of contact hypersensitivity are mediated by tumor necrosis factor-alpha. , 1992, The Journal of investigative dermatology.

[30]  J. Streilein,et al.  cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumor necrosis factor-alpha. , 1992, Journal of immunology.

[31]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[32]  R. Gallo,et al.  Tumor antigen presentation by murine epidermal cells. , 1991, Journal of immunology.

[33]  A. Heimberger,et al.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.

[34]  G. Greenoak,et al.  TOPICAL UROCANIC ACID ENHANCES UV‐INDUCED TUMOUR YIELD AND MALIGNANCY IN THE HAIRLESS MOUSE , 1989, Photochemistry and photobiology.

[35]  S. Howie,et al.  Ultraviolet-irradiated urocanic acid suppresses delayed-type hypersensitivity to herpes simplex virus in mice. , 1986, The Journal of investigative dermatology.

[36]  R. MacKie,et al.  CANCER, WARTS, AND SUNSHINE IN RENAL TRANSPLANT PATIENTS A Case-control Study , 1984, The Lancet.

[37]  F. Noonan,et al.  Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology , 1983, The Journal of experimental medicine.

[38]  B. Benacerraf,et al.  Impairment of antigen-presenting cell function by ultraviolet radiation. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Kripke.  Latency, histology, and antigenicity of tumors induced by ultraviolet light in three inbred mouse strains. , 1977, Cancer research.

[40]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[41]  M. Kripke,et al.  Antigenicity of murine skin tumors induced by ultraviolet light. , 1974, Journal of the National Cancer Institute.

[42]  M. R. Robertson,et al.  Skin cancer and immunosuppression. , 1971, Lancet.

[43]  R. Hofmann-Wellenhof,et al.  Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha. , 2000, The Journal of investigative dermatology.

[44]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[45]  M. Kripke,et al.  Immune surveillance against cutaneous malignancies in experimental animals. , 1989, Immunology series.

[46]  K. Wierzchowski.  [Photochemistry of nucleic acids]. , 1967, Postepy biochemii.